Irradiation dose to the swallowing apparatus impacts nutritional status in head and neck cancer patients—results from the prospective randomized HEADNUT trial Anna FingerMaximilian GrohmannAnastassia Löser Original Article Open access 17 August 2023 Pages: 875 - 880
Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer Zdenka PechacovaRadka LohynskaTomas Korinek Original Article Open access 12 April 2023 Pages: 881 - 890
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community Katharina LayerJulian P. Layerthe German-Speaking Radiation Dermatitis Survey Group Original Article Open access 26 April 2023 Pages: 891 - 900
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity Arnaud BeddokXavier MaynadierValentin Calugaru Original Article 31 May 2023 Pages: 901 - 909
Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers Busra YilmazEfsun SomayUgur Selek Original Article 11 August 2023 Pages: 910 - 921
Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center Henry Finlay GodsonJose Solomon RajRajesh Balakrishnan Original Article 06 June 2023 Pages: 922 - 935
Abnormal visual and olfactory sensations during radiation therapy: a prospective study Yiling MaiCelina VogelThomas Hummel Original Article Open access 04 June 2023 Pages: 936 - 949
The evolving role of reduced-dose total skin electron beam therapy in skin malignancies: the renaissance of a rare indication Khaled ElsayadHans Theodor Eich Short Communication Open access 14 July 2023 Pages: 950 - 953
Therapieentscheidungen beim hepatozellulären Karzinom: Erkenntnisse aus der TRENDY-Studie Danny JazmatiJudit Boda-HeggemannDavid Krug Literatur kommentiert Open access 31 August 2023 Pages: 954 - 956
Stereotaktische Radiotherapie plus Nivolumab bei NSCLC David KrugJürgen Dunst Literatur kommentiert Open access 29 August 2023 Pages: 957 - 959